Clinical impacts of DNA-based typing and provision of antigen-matched red blood cell units for chronically transfused patients with thalassemia

1. Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006;16:200–3. Wang LY Liang DC Liu HC , Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan . Transfus Med 2006 ; 16 : 200 – 3 . 10.1111/j.1365-3148.2006.00656.x16764599 Search in Google Scholar

2. Zaidi U, Borhany M, Ansari S, et al. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Transfus Med 2015;25:106–10. Zaidi U Borhany M Ansari S , Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan . Transfus Med 2015 ; 25 : 106 – 10 . 10.1111/tme.1219625870030 Search in Google Scholar

3. Elhence P, Solanki A, Verma A. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review. Indian J Hematol Blood Transfus 2014;30:301–8. Elhence P Solanki A Verma A. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review . Indian J Hematol Blood Transfus 2014 ; 30 : 301 – 8 . 10.1007/s12288-013-0311-y424340225435732 Search in Google Scholar

4. Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58:50–5. Spanos T Karageorga M Ladis V Peristeri J Hatziliami A Kattamis C. Red cell alloantibodies in patients with thalassemia . Vox Sang 1990 ; 58 : 50 – 5 . 10.1111/j.1423-0410.1990.tb02055.x2316211 Search in Google Scholar

5. Al-Riyami AZ, Al-Muqbali A, Al-Sudiri S, et al. Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review. Transfusion 2018;58:871–8. Al-Riyami AZ Al-Muqbali A Al-Sudiri S , Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review . Transfusion 2018 ; 58 : 871 – 8 . 10.1111/trf.1450829399805 Search in Google Scholar

6. Abdelrazik AM, Elshafie SM, El Said MN, et al. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Transfusion 2016;56: 2303–7. Abdelrazik AM Elshafie SM El Said MN , Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt . Transfusion 2016 ; 56 : 2303 – 7 . 10.1111/trf.1369527351342 Search in Google Scholar

7. Fucharoen S, Taphaichitr VS, Torcharus K, Viprakasit V. Clinical practice guidelines for diagnosis and management of thalassemia symdromes (in Thai). Bangkok, Thailand: P.A. Living, 2014. Fucharoen S Taphaichitr VS Torcharus K Viprakasit V. Clinical practice guidelines for diagnosis and management of thalassemia symdromes (in Thai) . Bangkok, Thailand : P.A. Living , 2014 . Search in Google Scholar

8. Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201. Fasano RM Chou ST . Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications . Transfus Med Rev 2016 ; 30 : 197 – 201 . 10.1016/j.tmrv.2016.05.01127345938 Search in Google Scholar

9. Dhawan HK, Kumawat V, Marwaha N, et al. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci 2014;8:84–8. Dhawan HK Kumawat V Marwaha N , Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients . Asian J Transfus Sci 2014 ; 8 : 84 – 8 . 10.4103/0973-6247.137438414006925161344 Search in Google Scholar

10. Thedsawad A, Taka O, Wanachiwanawin W. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias. Hematology (Amsterdam, Netherlands) 2019;24:208–14. Thedsawad A Taka O Wanachiwanawin W. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias . Hematology (Amsterdam, Netherlands) 2019 ; 24 : 208 – 14 . 10.1080/16078454.2018.154981830479186 Search in Google Scholar

11. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369–73. Singer ST Wu V Mignacca R Kuypers FA Morel P Vichinsky EP . Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent . Blood 2000 ; 96 : 3369 – 73 . 10.1182/blood.V96.10.3369 Search in Google Scholar

12. Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003;43:1604–10. Ameen R Al-Shemmari S Al-Humood S Chowdhury RI Al-Eyaadi O Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients . Transfusion 2003 ; 43 : 1604 – 10 . 10.1046/j.1537-2995.2003.00549.x14617321 Search in Google Scholar

13. Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology (Amsterdam, Netherlands) 2010;15:174–7. Pahuja S Pujani M Gupta SK Chandra J Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin . Hematology (Amsterdam, Netherlands) 2010 ; 15 : 174 – 7 . 10.1179/102453309X1258334711401320557678 Search in Google Scholar

14. Romphruk AV, Simtong P, Butryojantho C, et al. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital. Transfusion 2019;59:177–84. Romphruk AV Simtong P Butryojantho C , The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital . Transfusion 2019 ; 59 : 177 – 84 . 10.1111/trf.1500230443908 Search in Google Scholar

15. Trompeter S, Cohen A, Porter J. Blood transfusion. In: Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, Eds. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Thalassemia International Federation TIF Publication No. 20; 2014:28–41. Trompeter S Cohen A Porter J. Blood transfusion . In: Cappellini MD Cohen A Porter J Taher A Viprakasit V , Eds. Guidelines for the management of transfusion dependent thalassemia (TDT) . 3 rd ed. Thalassemia International Federation TIF Publication No. 20 ; 2014 : 28 – 41 . Search in Google Scholar

16. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.5.2. Atlanta, GA: U.S. Centers for Disease Control and Prevention. April 2018.Available from www.cdc.gov/nhsn. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.5.2 . Atlanta, GA : U.S. Centers for Disease Control and Prevention . April 2018 .Available from www.cdc.gov/nhsn. Search in Google Scholar

17. Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sanguinis 2014;106:197–208. Matteocci A Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing . Vox Sanguinis 2014 ; 106 : 197 – 208 . 10.1111/vox.1208624117723 Search in Google Scholar

18. Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016;2016:446–51. Hendrickson JE Tormey CA . Understanding red blood cell alloimmunization triggers . Hematology Am Soc Hematol Educ Program. 2016 ; 2016 : 446 – 51 . 10.1182/asheducation-2016.1.446614245727913514 Search in Google Scholar

19. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528–37. Yazdanbakhsh K Ware RE Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management . Blood 2012 ; 120 : 528 – 37 . 10.1182/blood-2011-11-327361340121322563085 Search in Google Scholar

20. Rujirojindakul P, Flegel WA. Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand. Blood Transfus 2014;12:28–35. Rujirojindakul P Flegel WA . Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand . Blood Transfus 2014 ; 12 : 28 – 35 . Search in Google Scholar

21. Yee MEM, Josephson CD, Winkler AM, et al. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia. Transfusion 2017;57:2738–46. Yee MEM Josephson CD Winkler AM , Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia . Transfusion 2017 ; 57 : 2738 – 46 . 10.1111/trf.14282567353428840600 Search in Google Scholar

22. Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012;52:2220–4. Cheng CK Lee CK Lin CK . Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review . Transfusion 2012 ; 52 : 2220 – 4 . 10.1111/j.1537-2995.2012.03570.x22339270 Search in Google Scholar

23. Luban NL. Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. Am J Pediatr Hematol Oncol 1989;11:314–9. Luban NL . Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background . Am J Pediatr Hematol Oncol 1989 ; 11 : 314 – 9 . Search in Google Scholar

24. Shaz BH, Hillyer CD. Minority donation in the United States: challenges and needs. Current Opin Hematol 2010;17:544–9. Shaz BH Hillyer CD . Minority donation in the United States: challenges and needs . Current Opin Hematol 2010 ; 17 : 544 – 9 . 10.1097/MOH.0b013e32833e5ac7308220220717026 Search in Google Scholar